New Mpox Outbreak Reaches Guinea Bissau Amid Global Spread Affecting Children
Quick Brief
Mpox has returned to global headlines with a fresh outbreak that includes Guinea Bissau's first-ever recorded cases. While previous outbreaks were historically confined to a small number of endemic African nations, the virus has now spread broadly. Notably, children appear to be particularly affected in these emerging cases.
What Happened?
A new wave of mpox has emerged, bringing the virus to Guinea Bissau for the first time. Globally, public health emergencies in 2022 and 2024 propelled the virus across 145 countries, accumulating nearly 190,000 lab-confirmed cases. This current cycle of the virus has drawn attention due to its impact on children.
Why It Matters
The spread of mpox to new regions like Guinea Bissau, alongside a high volume of global laboratory-confirmed cases since 2022, highlights the evolving footprint of a disease that was once limited to a handful of endemic African nations.
Key Facts
- Guinea Bissau has reported its first-ever outbreak of mpox.
- Nearly 190,000 lab-confirmed mpox cases have been recorded globally across 145 countries since 2022.
- Public health emergencies involving the virus occurred in 2022 and 2024.
- Children appear to be particularly affected in the newest wave of cases.
- Historically, outbreaks were small and restricted to a handful of endemic African countries.
Compiled from 2 outlets
Related Stories
Two Frankfurt Airport Workers Die of Malaria Likely Spread by Aircraft Mosquito
Two airport employees in Germany have died from malaria, while four additional colleagues fell ill. Authorities indicate the infections were likely transmitted by a mosquito that arrived on an airplane at Frankfurt Airport. Officials have urged the public to remain calm following the incident.
Kazia Therapeutics Announces 100% Clinical Benefit Rate in Advanced Triple-Negative Breast Cancer Trial
Kazia Therapeutics announced a 100% clinical benefit rate in the first six evaluable patients treated for advanced triple-negative breast cancer. The trial noted a durable complete metabolic response ongoing since November 2025. Furthermore, no treatment-related serious adverse events were observed during the study.
Novogene to Open Its First Australian Laboratory at Cabrini Health
Global genomics and multi-omics organization Novogene is launching its very first Australian laboratory located at Cabrini Health. The new facility aims to bring advanced genomic capabilities directly to Australian researchers and patients. Additionally, the initiative is designed to shorten waiting times for crucial genomic test results.